Pancreatic cancer.
Conditions
Interventions
Observation Group for Pancreatic Cancer Treatment:None
Sponsors
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Sign the informed consent form; 2. Age >=18 years old; 3. Be capable of complying with the plan; 4. Patients clinically diagnosed with pancreatic cancer or suspected of having pancreatic cancer; 5. Those who can cooperate during the PET/CT examination and successfully complete the examination process;
Exclusion criteria
Exclusion criteria: 1.Patients with a prior history of any other malignancy; 2.Individuals who are unable or unwilling to provide written informed consent; 3.patients who fail to complete the PET/CT examination within the specified time window; 4.Subjects who withdraw from the clinical study before completion;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Optimal TBR cutoff for FAPI-based diagnosis;Optimal SUVmax cutoff for FAPI-based diagnosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Determine the combined diagnostic performance of FAPI + FDG.; | — |
Countries
China
Contacts
Public ContactCai Xin;Cheng Jingyi
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Outcome results
None listed